Stem Cells 5 Flashcards

1
Q

Describe targets of stem cell based therapeutic strategy

A

Stem cell or (micro) environment = niche

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe modes of manipulation of stem cell based therapeutic strategy

A

Exogenous = in vitro, ex vivo
Endogenous = in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe exogenous stem cell based therapeutic strategy

A

Pluripotent or adult stem cell —>
stem cell isolation = to increase stem cells by positive selection or by eliminating unessecary cells
stem cell propagation = small fraction of cell lineage, need to expand pop - recall not many stem cells —>
Transplantation (to site of body where tissue needs to be regenerated) —> regeneration or
Differentiation modification (induce differentiation at a Certain level)—> transplantation —> regeneration (hope that regeneration occurs)

Artificial niche —> sc manipulation —> transplantation (into body or pure artificial niche in diseased site)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe endogenous stem cell based therapeutic strategy

A

Often used pharmacological manipulation - drugs, to control fate of stem cells (or viruses = many things) =
Scs = renewal, differentiation, mobilization, death (in cases of cancer stem cells)
Or
Niches = activation, inhibition, control, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is stem cell therapy based on - what does it target

A

Targets cause of pathology not symptoms —> not manipulating symptoms or handle them
Issues tho = stem cells small and do not proliferate much, pluripotent stem cells tumorigenic, but adult stem cells are not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe muscle stem cells

A

Satellite cells = have regeneration ability, sit on muscle fiver
Basal membrane= on top and surrounding muscle fiber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe mesenchymal stem cells

A

Looks like fibroblast cells, very ambitious mesenchymal stem cells are derived from bone marrow stromatolites
And can produce many types of cells = bone, cartilage, muscle, stroke, tendon, adipocyte
Useful for clinical applications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe bone fractures generally

A

Can be complex or cause large gap = difficulty to treat
One leg shorter than other, by >10 cam diff = handicap,
Can be due to car accidents, developmental conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe an approach to fix bone gaps

A

Fill gaps with ceramic cylinder = rigidity corresponds to bones
Has pores so cells, bv and neurons can induce the pores
Enter scaffold to fix complex fracture of bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe canine model exp = Gen

A

Implantation of porous ceramics loaded with mscs = canine model
Ceramics was used as scaffold for regeneration by stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe canine model exp = no ceramic cylinder

A

Regeneration but still huge gap even after 4 months,
Little or no new bone formed, no union occurred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe canine model exp = With a ceramic cylinder no mesechymal stem cells

A

Bone fusing to ceramics and bone marrow invades cylinder, gap artificially closed
Union occured at host bone implant interfaces
Bone formation did not occur throughout entire implant
Not super stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe canine model exp = With ceramic cylinder and mesenchymal stem cells

A

Dipped cylinder in ecm (cells, collagen, laminin), so whole ceramic column covered then dunk into mesenchymal stem cells = sticks to ecm inside and out
Heavier appearance on x ray = indicate more bone regeneration = calcium precipitation
Scaffold embedded in and integrated = has more stability
Substantial callus formed around implants
Union at host bone - implant interfaces is evident
Better, stronger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Did the canine exp require immunodeficient dogs

A

A cellular scaffold made immunosupression unecessary while allowing stem cells to seed and start regeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe conclusions of canine exp

A

Engineering of stem cell niches is an approach to regenerative therapy using stem cells
Used in humans too, almost in lungs = to replace removed tissue, like trachea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What controls stem cell fate

A

Matrix elasticity
Ability of stem cells to communicate with environment and direct themselves to a certain fate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe exp - stem cell changes based on matrix elasticity - gen

A

Substrate is polyacrylamide gel (acellualr) with diff elasticity and is coated with ecm - collagen 1 - so cells can touch gel comfortably
Put msc in culture dish = plastic goatee with gel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe exp - stem cell changes based on matrix elasticity - specific hardness levels

A

Can change rigidity based on concentration of gel
Soft = cells branch out cytoplasm
Medium = cylindrical shape, not spreading, between the soft and hard types
Hard = spread wide cell, long
Cells have diff morphology based on gel - evolves over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe exp - stem cell changes based on matrix elasticity - branches graph

A

As gel gets harder = loses branches, more widespread tissue shape
Neurons = showed pattern of branches similar to what mesenchymal cells show
= soft gel supports cells to take neuronal morphology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe exp - stem cell changes based on matrix elasticity - spindle factor graph

A

At a certain elasticity = medium level, cells become muscle cells = myoblasts
If too hard = declines
Substrate elasticity induces stem cells to specific direction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are differentially expressed depending on elasticity

A

Cell type specific genes are differnitally expressed depending on elasticity
Anti body staining against specific proteins
Beta3 tubulin = neuroncell, soft gel
MyoD = TF, Muscle origin, expressed at medium softness only
CBFalpha1 = osteoblast, localized proteins in nucleus, hard gel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe what happens to factors as substrate elasticity increases

A

P-nfh - neuro = suppressed as gel gets harder
Medium on = myod
Bone specific starts being expressed when gel harder
Mesenchymal stem cells can feel what they are on, based on hard/softness
Bone exp = hard ceramic so makes bones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What can give cells different feels of stiffness

A

Thickness of substrate
Ex = under gel = plastic, so thicker gel = will feel softer
500nm gel = thinner so bone
70um gel = thicker to less characteristic of osteoblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe sustaining potential of skeletal muscle stem cells - how and Gen exp setup

A

Muscle stem cell isolation —> purified —> 7 day culture musc (on substrates with diff elasticities)—> transplantation into damaged tissue (killl muscle cells first with toxin) —> histology to see

25
Q

Describe sustaining potential of skeletal muscle stem cells - hard gel

A

If culture on v hard gel = do not generate muscle = lose muscle characteristics
Needs specific elasticity fo substrate to maintain stem cells

26
Q

Describe sustaining potential of skeletal muscle stem cells - softer gel

A

More stem cells transplanted = the more regeneration occured
Need specific in vitro culture to maintain cell abilities

27
Q

Wha can stem cells do

A

Converse with substrate and coordinate their fates according to environment
Fate already determined so want to encourage to keep their functions
Modification of environment contributes to improvement of stem cell manipulation efficiency
Space of engineering attempts —> concept can be used for bioengineering

28
Q

Describe sphere culture system

A

Applicable to diff stem cell types
Neural stem cells, Mammary gland stem cells, retinal stem cells, skin derived progenitor cells, neuro/glioblatoma stem cells, breast cancer stem cells
Can all becomes sphere cells = cell structures can be applied for drug screening

29
Q

Describe neuropshere for drug discovery - 1

A

Made neuorsphres containing nscs - culture and exposed to many test compounds

30
Q

Describe neuropshere for drug discovery -2

A

New or approved compounds - applied certain concentration of drugs
(If find good candidate compound = to treat certain conditions or disease or manipulate stem cells = do not need approval)

See viability’s of cells
Some encourage proliferation - top
At bottom = to kills them, like if came from cancer cell

31
Q

Describe neuropshere for drug discovery - generating lead compounds

A

Compound libraries = can have 10 000 compounds
Can be fda approved compounds or naturally derived compounds or can make small molecules by collaborating with chemical engineers

32
Q

Describe neuropshere for drug discovery - high content analysis - high throughput screening

A

384 well plate screening, can do 384 compounds if do 10 = 3840 compounds = everything automatic
Automatic system to measure parameters
Automated plate delivery, auto focus, expose and acquire - fluorescence based, automated image analysis, automatic data archival, automatic data spooling to the server, instantaneous data display, analysis of results

33
Q

Describe neuropshere for drug discovery - 3

A

See what it looks like
Good survival or no

34
Q

Describe neuropshere for drug discovery- 4

A

Specific assay for a compound

35
Q

Describe stem cell based cell and gene therapy

A

Therapy based on stem cell targets = cause of pathology not symptoms
Modify genes before transplantation

36
Q

Describe use of retroviral vectors for stem cell based gene/cell therapies - deliver

A

Deliver a missing gene in stem cells =
Retrovirus (inclu lentivirus)= delivers a gene of inserts into host cell genome, integrates, permanent expression of genes
Ex= adenosine deaminase to hscs (required for function of lymphocytes)

37
Q

Describe use of retroviral vectors for stem cell based gene/cell therapies - viral vectors

A

Use of viral vectors as delivery tools = efficient, can deliver gene into genome
Words in vitro an in vivo
Targets many cells at once
Can be permanent = since genomic integration of transgene

38
Q

Describe use of retroviral vectors for stem cell based gene/cell therapies- risks

A

Risk of genetic modification
Random integration = do not really know where goes - randomly
Immune reaction = some cases
(Covid - adenovirus was used to deliver spike protein, causes more side effects since we all have antibodies against adenovirus)

39
Q

Uni of Pennsylvania 1999, exp - describe

A

Ornithine transcarbamylase deficiency (affects urinate system = urea, usually treat with diet and medicines v restrictive)
- Massive immune response to an adenoviral vector (injected into blood of patient and had short v aggressive immune response that attacked organs)
- Multiple organ failure (boy dead ar 18, was shown in animal models but researchers ignored it)

40
Q

Necker sick children hospital, Paris, 2002 - describe

A

Severe immunodeficiency (delivered genes to overcome this)
- Radom integration of a therapeutic gene
in the genome of patients’ cells,
using a retroviral vector for gene delivery (immune systems recovered)
- Emergence of rare T-cell leukemia 3 years after the gene therapy. (Random integration of retroviral genes of kidneys - into genome)
Buds outcomes bolted gene therapy trials

41
Q

Why escs needed for gene targeting

A

Aggressive proliferation
Non viral approach - more frequent/sucessfully done
But adult stem cells do not divide like es cells so difficult

42
Q

Describe Gen editing - gen

A

Immunological defence mechanism of bacteria
When virus comes in = use this sequence to bind genome of virus
Not gene targeting

43
Q

Describe Gen editing - specifics

A

Crispr = site recognition - loop shape of sequence derived from bacterial virus, so use sequence to bind genome of virus and destroy it
Cas9 = enzyme, cleavage - done using guide rna, can modify rna
Can induce diff functions
Site specific - non specific recognition of target protein does not happen bc super specific
Technically more straightforward than other methods

44
Q

Describe Gen editing - what can you do with crispr/cas9 system

A
  • Introducing insertion/deletion mutations
  • Replacing one sequence with another
  • Introducing base substitutions
  • Adding a new sequence
  • Editing multiple genes at the same time
  • Modifying/controlling gene transcription
  • Modifying/controlling epigenetics
  • Manipulating RNAs.
45
Q

Describe anemias caused by genetic disorders affects erythrocytes

A

Sickle cell anemia = point mutations in globin gene
B thalassemia = insufficient production of globin - due to mutation in enhancer

46
Q

What is therapeutic strategy to treat anemia - 5 steps

A
  1. Harvest hematopoietic stem cells (HSCs) from a patient.
  2. Interrogate the HSC genome and correct the mutation in the globin gene ex vivo by gene editing or gene targeting. (Identify mutation by examining genome)
  3. Transfer the modified HSCs back into the patient.
  4. HSCs engraft (no immune problems) and continuously produce erythrocytes with normal globins.
  5. A complete and permanent cure, that requires no pharmacological intervention.
    (or, the therapy may need to be repeated if HPCs were modified)
47
Q

Why is b thalassemia harder to treate

A

Sickle cell = 1 point mutation
But b thalassemia = >350 diff mutations, to target in each patient = very hard and labour intensive
Both caused by mutations in beta globin gene and have same clinical symptoms

48
Q

Describe concept of strategy to help anemia

A

Adult globin gene is mutation (bc adults can be exposed to malaria) - FETAL GLOBIN GENE IS NOT
Forced expression of fetal globin (gamma globin), leading to production of fetal hemoglobin in addition to adult hemoglobin (wake up gamma globin, capacity of carrying oxygen a bit Lower than adult one)
Gene editing in hscs/hpcs that allows for gamma globin in erythrocytes in adult patients

49
Q

What induced gamma globin gene

A

Knocking down bcl11a - tf regulator, binds and suppressed gamma globin gene in erythroid lineage
Sirna = breaks down bcl11a = inhibit translation of protein, less expression so gamma globin expressed
Transcriptional suppression of bcl11a should lead to fetal globin and production of fetal hemoglobin in adults

50
Q

Describe editing bcl11a enhancer - Gen

A

Diff types = show position of guide rnas, needed to confirm one works
Gata = site where specific tf binds to stimulate gene - target here, important so know to target here - target enhancer
introduction of mutations in a specific region of bcl11a enhancer region, using crispr-cas9 technology
If hit 1617 = most effective to stimulate gamma globin
Rise in gamma globin should correspond to supresssion of bcl11a expression
More fetal type globin expressed as less bcl11mrna = inverse correlation

51
Q

Describe editing bcl11a enhancer - what does disruption of gata binding sequence in enhancer do

A

1) To reduce BCL11A expression;
2) To reactivate g-globin expression;
3) For both to occur in the erythroid lineage (because the GATA motif is critical in the erythroid lineage)

52
Q

Describe more preclinical testing done to check if anemia exp worked

A

1) Human hematopoietic stem/progenitor cells (HSPCs) were extracted from two SCD (sickle cell disease) patients.
2) Gene editing was done in vitro on the BCL11A enhancer in HSPCs using the CRISPR-Cas9 technique (using Sequence 1617).
3) Patients’ modified HSPCs were transplanted into “immunodeficient” mice.
4) Different types of human blood cells were harvested from mouse bone marrow 16 weeks later.
5) Various analyses done at the levels of transcripts (mRNA), proteins, and cells.

(Took cells out of patients, edit and transplant to mouse and measure human cels in blood of mouse)

53
Q

Describe engraftment of edited cells - exp results

A

After editing = no effect really - still same % of human cells and induced mutation %
Wel maintained after transplantation, similar prevalence of induced mutation, nearly 100%

54
Q

Describe erythroid specific effects protein - exp results

A

Bcl11a in B CELLS = not affect by genetic editing
Bcl11a in eyrthoid cells = gene editing resulted in reduction of protein expression of bcl11a specifically in blood cell lineage - inverse correlation

55
Q

Describe gamma globin expression - exp results

A

Expressed for after gene editing

56
Q

Describe erythroid specific effects protein - biological assay

A

Mbs = sodium metabisulfite test- diff osmotic pressure such that rubs will show sickle shape if not edited = unedited
So can see normal morphology maintained of edited cells

57
Q

Has anemia exp even done irl

A

Applied clinically but must treat with bone marrow meds (one to damage bone marrow)- if have to do to kids in Africa, = more sensitive maybe
Similar approaches used- device and developing but sucessful cases have been reported

58
Q

Describe what stem cell based therapies do - summary

A

Stem cell-based therapies (cell therapy, regenerative medicine) can overcome a disease state and achieve a complete cure, rather than alleviating symptoms.
Gene editing adds a precision to stem cell-based gene therapy. (if it is indeed safe)
Next generation stem cell therapy

59
Q

What does gene therapy need to satisfy

A

Does it work
Is it safe = most important
Does it pay off (if too costly, or hard to apply)